“…Characterization of mutations in mitochondrially encoded OXPHOS complex genes provided evidence for their role in tumor development and progression. Previous studies have demonstrated that mitochondrial mutations are associated with elevated ROS production [27,39], increased invasion ability [40,41], decimated mitochondria copy number [39,42], and higher risk of breast cancer [21], oral squamous cell carcinoma [39,43], colorectal cancer [12,44], and thyroid oncocytoma [39,45]. The existence of empirical evidence for mitochondrial genomic mutations and subsequent mitochondrial dysfunction in several cancers suggests that mitochondrial mutations may have potential in evaluating the risk of cancer progression [19,20,28,39,41,43].…”